Consolidated Statements of Changes in Stockholders’ Equity - USD ($) $ in Thousands	Predecessor Common Stock	Predecessor Additional Paid-In Capital	Predecessor Accumulated Deficit	Predecessor	Successor Common Stock	Successor Additional Paid-In Capital	Successor Accumulated Deficit	Successor
Balance at Dec. 31, 2019		$ 18,717	$ (10,924)	$ 7,793	$ 2	$ 90,828	$ (43,661)	$ 47,169
Balance (in Shares) at Dec. 31, 2019	1,000				19,753,061
Net loss			(1,589)	(1,589)
Balance at Apr. 06, 2020		$ 18,717	$ (12,513)	$ 6,204	$ 1		(17,081)	(17,080)
Balance (in Shares) at Apr. 06, 2020	1,000				7,932,977
Conversion of rights (previously issued in the IPO) into shares
Conversion of rights (previously issued in the IPO) into shares (in Shares)					3,105,000
Issuance of shares in connection with the acquisition of Computex (as defined in Note 1)					$ 1	24,567		24,568
Issuance of shares in connection with the acquisition of Computex (as defined in Note 1) (in Shares)					8,189,490
Additional shares issued in connection with the acquisition of Computex (working capital adjustment)						557		557
Additional shares issued in connection with the acquisition of Computex (working capital adjustment) (in Shares)					117,231
Issuance of shares in exchange for services						1,500		1,500
Issuance of shares in exchange for services (in Shares)					500,000
Deferred underwriting fees relating to IPO						(3,000)		(3,000)
Debenture discount relative to fair value of warrants and beneficial conversion feature						64,715		64,715
Redemption of shares held in trust							(1,004)	(1,004)
Redemption of shares held in trust (in Shares)					(91,637)
Vested and delivered RSUs
Share-based compensation						2,489		2,489
Net loss							(25,576)	(25,576)
Balance at Dec. 31, 2020					$ 2	90,828	(43,661)	47,169
Balance (in Shares) at Dec. 31, 2020					19,753,061
Conversion of rights (previously issued in the IPO) into shares
Sale of common stock, preferred stock and Series D Warrants					$ 1	23,199		23,200
Sale of common stock, preferred stock and Series D Warrants (in Shares)					7,840,000
Less fair value of Preferred Stock						(12,456)		(12,456)
Less fair value of Series D warrants						(9,844)		(9,844)
Sale of common stock, Series A and Series B warrants						4,585		4,585
Sale of common stock, Series A and Series B warrants (in Shares)					2,500,000
Less fair value of Series A and Series B Warrants						(3,175)		(3,175)
Common stock issued on exercise of Series B Warrants						8,171		8,171
Common stock issued on exercise of Series B Warrants (in Shares)					3,333,334
Common stock issued on exercise of Series C Warrants						1,545		1,545
Common stock issued on exercise of Series C Warrants (in Shares)					1,500,000
Common stock issued on conversion of Preferred Stock					$ 1	12,455		12,456
Common stock issued on conversion of Preferred Stock (in Shares)					7,785,000
Common stock issued on conversion of Debentures					$ 4	109,691		109,695
Common stock issued on conversion of Debentures (in Shares)					38,811,223
Common stock issued on conversion of Penny Warrants					$ 1	1		2
Common stock issued on conversion of Penny Warrants (in Shares)					6,243,308
Cumulative effect of accounting change related to adoption of ASU 2020-06 (See Note 3)						(36,983)	1,219	(35,764)
Debenture discount relative to fair value of warrants						9,223		9,223
Vested and delivered RSUs
Vested and delivered RSUs (in Shares)					975,000
Shares repurchased for tax withholding						(1,148)		(1,148)
Shares repurchased for tax withholding (in Shares)					(156,153)
Share-based compensation						8,629		8,629
Net loss							(161,386)	(161,386)
Balance at Dec. 31, 2021					$ 9	$ 204,721	$ (203,828)	$ 902
Balance (in Shares) at Dec. 31, 2021					88,584,773